In Defense of Trazodone
You may have missed Dr. Daniel Carat’s defense of Trazodone in the New York Times. Trazonde, classified as an antidepressant, is used off-label to treat insomnia because it works well, is non-addictive and can be used long term. Dr. Carat, a highly respected research doctor, claims that drug companies are mounting attacks on trazonde, because it cost less than their products.
In the past few years, several articles have been published in professional journals that can only be described as trazodone-bashing, says Carat. But Carat notes that the authors of the studies have been paid by the companies that stand to gain from trazodone’s downfall.
I’m not endorsing Trazodone. But, give the defense by this noted authority, its benefits, and its minimal exposure in the media, it might be worth asking your doctor about it.
